Pirayesh A, Dur A H M, Paauw N J, Monstrey S, Kreis R W, Hoekstra M J, Richters C D
Plastic Surgery, UZ Gent, Gent, Belgium.
Eur Surg Res. 2008;41(4):346-52. doi: 10.1159/000161079. Epub 2008 Oct 8.
Abdominal wall repair can be performed with synthetic or biological materials. Biological materials may reduce the risk of infections and fibrosis. The aim of this study was to evaluate two acellular human dermis products.
A rat model was used to compare the two materials. One was prepared using low concentrations of NaOH; the other material was SureDerm, which is commercially available. Full thickness defects were prepared in the abdominal wall and closed with the materials. Rats were sacrificed at 1 or 4 months after operation and the numbers of adhesions to the bowels were scored. Samples were taken for histological analysis and to measure the breaking strength.
In both groups a good functional integration of the implants with the abdominal wall was observed. There was no adhesion formation with the bowels in the group with the NaOH prototype. In the SureDerm group, 4 out of 7 rats showed only small adhesions at 4 months after operation. Breaking strength of the healed tissue was significantly higher in the NaOH prototype group at 4 months after operation (p < 0.0026).
The results indicate that both human acellular dermis products may be used in clinical trials for closure of abdominal wall defects.
腹壁修复可使用合成材料或生物材料进行。生物材料可能会降低感染和纤维化的风险。本研究的目的是评估两种脱细胞人真皮产品。
使用大鼠模型比较这两种材料。一种是用低浓度氢氧化钠制备的;另一种材料是市售的SureDerm。在腹壁制备全层缺损并用这些材料进行闭合。术后1个月或4个月处死大鼠,对肠粘连数量进行评分。采集样本进行组织学分析并测量断裂强度。
两组均观察到植入物与腹壁良好的功能整合。在氢氧化钠原型组中未形成肠粘连。在SureDerm组中,7只大鼠中有4只在术后4个月仅显示轻微粘连。术后4个月,氢氧化钠原型组愈合组织的断裂强度显著更高(p < 0.0026)。
结果表明,两种脱细胞人真皮产品均可用于腹壁缺损闭合的临床试验。